Everything below concerns bremelanotide. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-07-20. Numbers and descriptions here follow the published literature rather than marketing material.
The lyophilised solid is relatively stable when kept dry, protected from light and held at reduced temperature, commonly minus 20 degrees Celsius or lower for long-term storage. In solution the peptide is more vulnerable: tryptophan oxidation, hydrolysis of the lactam bridge and aggregation all become relevant over time, and the rate depends on pH, buffer composition and concentration. Repeated freeze-thaw cycles are generally avoided because they promote aggregation. Aqueous working solutions are typically prepared fresh or split into single-use aliquots to limit degradation before analysis.
Published studies differ in design, population and endpoint definition, so results are not always directly comparable across reports. Some trials used patient-reported measures of desire and distress, while others tracked physiological or behavioural outcomes. Questions that remain open include the durability of effects beyond short follow-up periods, the frequency of transient blood pressure elevation observed after administration, and whether a subtype-selective analogue could separate central effects from pigmentation-related activity. These points are usually framed as unresolved rather than settled in review literature.
PT-141 is the research code for bremelanotide, a cyclic heptapeptide derived from alpha-melanocyte-stimulating hormone. The molecule belongs to the melanocortin receptor agonist family and shows highest affinity for the MC4 receptor subtype, with weaker activity at MC1, MC3 and MC5. Its structure retains the core His-Phe-Arg-Trp sequence that defines melanocortin recognition, while cyclization and terminal modifications improve metabolic stability relative to the parent hormone. Early work classified the compound as a centrally acting agent rather than a peripherally acting vasodilator, which shaped subsequent development priorities.
Receptor activation in hypothalamic and limbic circuits is the mechanism most often cited for the observed effects on sexual desire. Signalling through MC4R couples to Gs proteins and raises intracellular cyclic AMP, which in turn modulates dopaminergic tone in reward-related pathways. Because the peptide reaches the central nervous system after subcutaneous administration, peripheral vascular changes are regarded as secondary rather than primary. The precise neural circuits that translate receptor occupancy into behavioural change remain incompletely mapped, and published accounts describe the pathway in general terms rather than as a fully resolved sequence.
Development began with intranasal formulations investigated for erectile dysfunction, but blood pressure elevation limited that route and prompted a switch to subcutaneous delivery. Clinical testing then shifted toward hypoactive sexual desire disorder in premenopausal women, and a subcutaneous product received United States approval in 2019. Later trials examined other populations with mixed results, and questions about effect size, durability and patient selection remain open in the peer-reviewed literature. Research interest continues in parallel with the broader melanocortin field, where several synthetic analogues are studied together.
| Property | Value | Notes |
|---|---|---|
| Solubility class | Freely soluble in water | Also soluble in DMSO and some alcohols |
| Typical storage temperature | -20 C or below | Desiccated, protected from light |
| Common analytical method | RP-HPLC with UV detection | Often paired with mass spectrometry |
| Typical reported purity | 95 percent or higher | Reference-grade material |
| Common synonyms | PT-141 | Also called bremelanotide acetate |
Clinical development proceeded through two routes of administration. An intranasal formulation advanced first, but variable absorption and tolerability problems led to a switch to subcutaneous injection. The United States Food and Drug Administration approved the subcutaneous product in 2019 for hypoactive sexual desire disorder in premenopausal women. Marketing rights subsequently changed hands, and commercial availability has fluctuated since approval. Use in men, in postmenopausal women, and in combination with other agents remains outside the approved label.
Outside the approved product, bremelanotide circulates as a research chemical sold by peptide vendors, often labelled PT-141. Such material is not manufactured under pharmaceutical quality standards, and independent testing has repeatedly found content that differs from the label. Analytical certificates supplied with a purchase are not strong evidence of purity because they are usually generated by the seller. Online discussion tends to blur the distinction between the approved drug and unregulated powder, which complicates interpretation of reported experiences.
PT-141 is the original development code for bremelanotide, a synthetic peptide first studied as a potential tanning and sexual-response agent in the 1990s. Researchers at a small American biotechnology firm designed it as a shortened analogue of melanotan II, which itself came from work on alpha-melanocyte-stimulating hormone. Early screening focused on pigmentation, but behavioural observations in animal models redirected attention toward sexual motivation. That shift made PT-141 one of the first melanocortin compounds investigated specifically for effects on desire rather than on skin colour.
From a pharmacokinetic standpoint, the peptide is usually delivered by injection because oral bioavailability is very low; proteases in the digestive tract degrade it rapidly. After subcutaneous administration, plasma concentrations reach a peak within roughly one hour. Its elimination half-life is relatively short, with most reports placing it in the range of a few hours. Nasal formulations have also been examined, though absorption varies widely between individuals. Metabolism proceeds mainly through peptidase cleavage, and the resulting products are excreted by the kidneys.
PT-141 initiates cellular signaling by binding to specific subtypes within the melanocortin receptor family. These receptors belong to the G protein-coupled receptor superfamily, and activation raises intracellular cyclic adenosine monophosphate levels. This cascade ultimately influences neuronal circuits in the central nervous system that are associated with sexual desire and arousal. Research indicates the compound's action concentrates in hypothalamic regions rather than peripheral tissues, which helps explain some observed pharmacological features. The selectivity of receptor binding underlies its functional differences.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
== Discovery and structure == In 1991 a research group led by Clarence A. Ryan, isolated an 18 amino acid polypeptide from tomato leaves that induced the production of protease inhibitor proteins (PIs) in response to wounding. Experiments using synthetic radio-labelled forms of the polypeptide demonstrated that it was able to travel systemically through the plant and induce PI production in unwounded leaves. Because of the systemic nature of the wounding signal, it was named systemin, it was the first polypeptide found to function as a hormone in plants. mRNA encoding for systemin is found in all tissues of the plant except the roots. Later studies identified homologs of tomato systemin in other members of the Solanaceae including potato, black nightshade and bell pepper. Systemins have only been identified in the Solaneae subtribe of the Solanaceae, but other members of the family, such as tobacco, also respond to wounding by systemically producing protease inhibitors.
== Publications in English == Hahn, Otto (1936). Applied Radiochemistry. Ithaca, New York: Cornell University Press. Hahn, Otto (1950). New Atoms: Progress and Some Memories. New York-Amsterdam-London-Brussels: Elsevier Inc. Hahn, Otto (1966). Otto Hahn: A Scientific Autobiography. Translated by Ley, Willy. New York: Charles Scribner's Sons. Hahn, Otto (1970). My Life. Translated by Kaiser, Ernst; Wilkins, Eithne. New York: Herder and Herder.
Hyaluronic acid (; HA; conjugate base hyaluronate), also called hyaluronan, is an anionic, nonsulfated glycosaminoglycan distributed widely throughout connective, epithelial, and neural tissues. It is unique among glycosaminoglycans as it is non-sulfated, forms in the plasma membrane instead of the Golgi apparatus, and can be very large: human synovial HA averages about 7 MDa per molecule, or about 20,000 disaccharide monomers, while other sources mention 3–4 MDa. Medically, hyaluronic acid is used to treat osteoarthritis of the knee and dry eye, for wound repair, and as a cosmetic filler. These therapeutic uses are possible with modifications to HA, and more are still being developed. The average 70 kg (150 lb) person has roughly 15 grams of hyaluronan in the body, one third of which is turned over (i.e., degraded and synthesized) per day. As one of the chief components of the extracellular matrix, it contributes significantly to cell proliferation and migration, and is involved in the progression of many malignant tumors. Hyaluronic acid is also a component of the group A streptococcal extracellular capsule, and is believed to play a role in virulence. Chemical modifications to HA can improve certain properties such as biocompatibility, permeation, and sustained drug release. Common modification sites include the carboxyl, primary alcohol, and N-acetyl groups. These modifications include amidation, Ugi condensation, esterification, and etherification.
Sources: en.wikipedia.org
During FY2018, the federal government collected approximately $3.33 trillion in tax revenue, up $14 billion or less than 1% versus FY2017. Primary receipt categories included individual income taxes ($1,684B or 51% of total receipts), Social Security/Social Insurance taxes ($1,171B or 35%), and corporate taxes ($205B or 6%). Corporate tax revenues declined by $92 billion or 32% due to the Tax Cuts and Jobs Act. Other revenue types included excise, estate and gift taxes. FY 2018 revenues were 16.4% of gross domestic product (GDP), versus 17.2% in FY 2017. Tax revenues averaged approximately 17.4% GDP over the 1980-2017 period. During FY2017, the federal government collected approximately $3.32 trillion in tax revenue, up $48 billion or 1.5% versus FY2016. Primary receipt categories included individual income taxes ($1,587B or 48% of total receipts), Social Security/Social Insurance taxes ($1,162B or 35%), and corporate taxes ($297B or 9%). Other revenue types included excise, estate and gift taxes. FY 2017 revenues were 17.3% of gross domestic product (GDP), versus 17.7% in FY 2016. Tax revenues averaged approximately 17.4% GDP over the 1980-2017 period. Tax revenues are significantly affected by the economy. Recessions typically reduce government tax collections as economic activity slows. For example, tax revenues declined from $2.5 trillion in 2008 to $2.1 trillion in 2009, and remained at that level in 2010. From 2008 to 2009, individual income taxes declined 20%, while corporate taxes declined 50%.
conjugative - mediate DNA transfer through conjugation and therefore spread rapidly among the bacterial cells of a population; e.g., F plasmid, many R and some col plasmids. nonconjugative - do not mediate DNA through conjugation, e.g., many R and col plasmids.
== References == Chan, E.W.C; S.K. Wong (2009). "Chemical constituents of leaves of Rhizophora x lamarckii, R. apiculata and R. stylosa" (PDF). ISME/GLOMIS Electronic Journal. 7 (1): 1–2. Chan, H.T. (1996). "A note on the discovery of Rhizophora x lamarckii in Peninsular Malaysia" (PDF). Journal of Tropical Forest Science. 9: 128–130. Duke, N.C. (2006). “Australia’s Mangroves: The Authoritative Guide to Australia’s Mangrove Plants”. University of Queensland, Brisbane, 200 p. ISBN 0-646-46196-6. Tomlinson, P.B. (1986). “The Botany of Mangroves”. Cambridge University Press, 413 p. ISBN 0-521-25567-8.
==== Class B sub-family ==== Class B enzymes are the largest and most versatile which can methylate a wide range of carbon and phosphorus centers. These enzymes require a cobalamin (vitamin B12) cofactor as an intermediate methyl group carrier to transfer a methyl group from SAM to substrate. One well-investigated representative enzyme is TsrM which involves in tryptophan methylation in thiostrepton biosynthesis.
Sources: en.wikipedia.org
== Research == Gepirone is under development for the treatment of decreased libido and generalized anxiety disorder (GAD). As of October 2023, it is in phase III clinical trials for these indications. The pro-sexual effects of gepirone appear to be independent of its antidepressant and anxiolytic effects.
== War crimes == During the Battle of France, soldiers of the division perpetrated summary executions of hundreds of Black prisoners of war in French service. These executions were racially motivated, as German troops had been conditioned by Nazi propaganda to see Black people as subhuman. In several instances, Black prisoners of war were separated from White ones and murdered by soldiers of the division, including on 10 June 1940, where 150 Black prisoners were massacred in Erquinvillers. Another mass killing committed by the division was the Chasselay massacre; on 19-20 June hundreds of Black prisoners of war were murdered in Chasselay, Rhône.
Serous acinar cells are roughly pyramid shape, with the apex of the pyramid pointing towards to the center of the (roughly spherical) acinus. Inside of the cell on the side with the apex, there are specialize saliva-material containing structures called secretory granules. Compared to mucous acinar cells, their nuclei is more round, and centrally located.
In 1898, Marie and Pierre Curie discovered a strongly radioactive substance in pitchblende and determined that it was a new element; it was one of the first radioactive elements discovered. Having identified it as such, they named the element polonium after Marie's home country, Poland. Willy Marckwald discovered a similar radioactive activity in 1902 and named it radio-tellurium as it was chemically extracted with its homolog tellurium, and at roughly the same time, Ernest Rutherford identified the same activity in his analysis of the uranium decay chain and named it radium F (originally radium E). By 1905, Rutherford concluded that all these observations were due to the same substance, 210Po. Further discoveries and the concept of isotopes, first proposed in 1913 by Frederick Soddy, firmly placed 210Po as the penultimate step in the uranium series. In 1943, 210Po was studied as a possible neutron initiator in nuclear weapons, as part of the Dayton Project. In subsequent decades, concerns for the safety of workers handling 210Po led to extensive studies on its health effects. In the 1950s, scientists of the United States Atomic Energy Commission at Mound Laboratories, Ohio explored the possibility of using 210Po in radioisotope thermoelectric generators (RTGs) as a heat source to power satellites. A 2.5-watt atomic battery using 210Po was developed by 1958. However, the isotope plutonium-238 was chosen instead, as it has a longer half-life of 87.7 years. Polonium-210 was used to kill Russian dissident and ex-FSB officer Alexander V.
==== Italy, South Leigh and Prague ==== The following year, in April 1947, the Thomases travelled to Italy, after Thomas had been awarded a Society of Authors scholarship. They stayed first in villas near Rapallo and then Florence, before moving to a hotel in Rio Marina on the island of Elba. On their return, Thomas and family moved, in September 1947, into the Manor House in South Leigh, just west of Oxford, purchased and rented to Thomas for £1 per week by Margaret Taylor. He continued with his work for the BBC, completed a number of film scripts and worked further on his ideas for Under Milk Wood, including a discussion in late 1947 of The Village of the Mad (as the play was then called) with the BBC producer Philip Burton. He later recalled that, during the meeting, Thomas had discussed his ideas for having a blind narrator, an organist who played for a dog and two lovers who wrote to each other every day but never met. In March 1949 Thomas travelled to Prague. He had been invited by the Czech government to attend the inauguration of the Czechoslovak Writers' Union. Jiřina Hauková, who had previously published translations of some of Thomas's poems, was his guide and interpreter. In her memoir, Hauková recalls that at a party in Prague, Thomas "narrated the first version of his radio play Under Milk Wood." She describes how he outlined the plot about a town that was declared insane, mentioning the organist who played for sheep and goats and the baker with two wives.
Sources: en.wikipedia.org
The peptide is polar and charged, and reversed-phase chromatography with acidic mobile phases resolves it well from related substances. Ultraviolet detection near 214 nm gives adequate sensitivity without derivatisation.
Aqueous solutions are subject to oxidation and hydrolysis, so concentration and pH drift can occur even under refrigeration. Solid, dry material held cold and desiccated degrades far more slowly.
Mass spectrometry separates the parent from analogues that differ by a single modification, such as an amide versus acid terminus. Retention time alone is less reliable because closely related peptides can co-elute.
The code designates bremelanotide, a cyclic heptapeptide melanocortin receptor agonist. It served as an internal research identifier before the compound entered formal clinical development. The code and the generic name refer to the same molecule.